Literature DB >> 18391027

In vitro antifungal susceptibility and molecular characterization of clinical isolates of Fusarium verticillioides (F. moniliforme) and Fusarium thapsinum.

Mónica Azor1, Josepa Gené, Josep Cano, Deanna A Sutton, Annette W Fothergill, Michael G Rinaldi, Josep Guarro.   

Abstract

A microdilution method was used to test 11 antifungal drugs against clinical isolates of Fusarium thapsinum and three different phylogenetic clades of Fusarium verticillioides that were characterized by sequencing a region of the beta-tubulin gene. Terbinafine was the most-active drug against both species, followed by posaconazole against F. verticillioides.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18391027      PMCID： PMC2415809          DOI： 10.1128/AAC.00176-08

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  16 in total

1.  Cryptic species in Stachybotrys chartarum.

Authors:  Michael Cruse; Robin Telerant; Thomas Gallagher; Thomas Lee; John W Taylor
Journal:  Mycologia       Date:  2002 Sep-Oct       Impact factor: 2.696

2.  Antifungal susceptibility of 44 clinical isolates of Fusarium species determined by using a broth microdilution method.

Authors:  A Reuben; E Anaissie; P E Nelson; R Hashem; C Legrand; D H Ho; G P Bodey
Journal:  Antimicrob Agents Chemother       Date:  1989-09       Impact factor: 5.191

Review 3.  Micafungin: pharmacology, experimental therapeutics and clinical applications.

Authors:  Andreas H Groll; Theodouli Stergiopoulou; Emmanuel Roilides; Thomas J Walsh
Journal:  Expert Opin Investig Drugs       Date:  2005-04       Impact factor: 6.206

4.  In-vitro antifungal susceptibility of clinical and environmental Fusarium spp. strains.

Authors:  I Pujol; J Guarro; J Gené; J Sala
Journal:  J Antimicrob Chemother       Date:  1997-02       Impact factor: 5.790

5.  [Case report: a Fusarium fungaemia].

Authors:  Mine Yücesoy; M Cem Ergon; Hale Oren; Zeynep Gülay
Journal:  Mikrobiyol Bul       Date:  2004-07       Impact factor: 0.622

6.  Voriconazole treatment for less-common, emerging, or refractory fungal infections.

Authors:  John R Perfect; Kieren A Marr; Thomas J Walsh; Richard N Greenberg; Bertrand DuPont; Juliàn de la Torre-Cisneros; Gudrun Just-Nübling; Haran T Schlamm; Irja Lutsar; Ana Espinel-Ingroff; Elizabeth Johnson
Journal:  Clin Infect Dis       Date:  2003-04-22       Impact factor: 9.079

7.  Posaconazole as salvage treatment for invasive fusariosis in patients with underlying hematologic malignancy and other conditions.

Authors:  Issam I Raad; Ray Y Hachem; Raoul Herbrecht; John R Graybill; Roberta Hare; Gavin Corcoran; Dimitrios P Kontoyiannis
Journal:  Clin Infect Dis       Date:  2006-04-11       Impact factor: 9.079

8.  In vitro interactions of licensed and novel antifungal drugs against Fusarium spp.

Authors:  Montserrat Ortoneda; Javier Capilla; F Javier Pastor; Isabel Pujol; Josep Guarro
Journal:  Diagn Microbiol Infect Dis       Date:  2004-01       Impact factor: 2.803

9.  Phylogenetic diversity and microsphere array-based genotyping of human pathogenic Fusaria, including isolates from the multistate contact lens-associated U.S. keratitis outbreaks of 2005 and 2006.

Authors:  Kerry O'Donnell; Brice A J Sarver; Mary Brandt; Douglas C Chang; Judith Noble-Wang; Benjamin J Park; Deanna A Sutton; Lynette Benjamin; Mark Lindsley; Arvind Padhye; David M Geiser; Todd J Ward
Journal:  J Clin Microbiol       Date:  2007-05-16       Impact factor: 5.948

Review 10.  Fusarium infections in immunocompromised patients.

Authors:  Marcio Nucci; Elias Anaissie
Journal:  Clin Microbiol Rev       Date:  2007-10       Impact factor: 26.132
View more
  13 in total

1.  Internet-accessible DNA sequence database for identifying fusaria from human and animal infections.

Authors:  Kerry O'Donnell; Deanna A Sutton; Michael G Rinaldi; Brice A J Sarver; S Arunmozhi Balajee; Hans-Josef Schroers; Richard C Summerbell; Vincent A R G Robert; Pedro W Crous; Ning Zhang; Takayuki Aoki; Kyongyong Jung; Jongsun Park; Yong-Hwan Lee; Seogchan Kang; Bongsoo Park; David M Geiser
Journal:  J Clin Microbiol       Date:  2010-08-04       Impact factor: 5.948

Review 2.  Sequence-based identification of Aspergillus, fusarium, and mucorales species in the clinical mycology laboratory: where are we and where should we go from here?

Authors:  S A Balajee; A M Borman; M E Brandt; J Cano; M Cuenca-Estrella; E Dannaoui; J Guarro; G Haase; C C Kibbler; W Meyer; K O'Donnell; C A Petti; J L Rodriguez-Tudela; D Sutton; A Velegraki; B L Wickes
Journal:  J Clin Microbiol       Date:  2008-12-10       Impact factor: 5.948

3.  Use of matrix-assisted laser desorption ionization-time of flight mass spectrometry for identification of molds of the Fusarium genus.

Authors:  David Triest; Dirk Stubbe; Koen De Cremer; Denis Piérard; Anne-Cécile Normand; Renaud Piarroux; Monique Detandt; Marijke Hendrickx
Journal:  J Clin Microbiol       Date:  2014-11-19       Impact factor: 5.948

Review 4.  Fusarium infection in lung transplant patients: report of 6 cases and review of the literature.

Authors:  Herman A Carneiro; Jeffrey J Coleman; Alejandro Restrepo; Eleftherios Mylonakis
Journal:  Medicine (Baltimore)       Date:  2011-01       Impact factor: 1.889

5.  Potent Activities of Luliconazole, Lanoconazole, and Eight Comparators against Molecularly Characterized Fusarium Species.

Authors:  Mahdi Abastabar; Abdullah M S Al-Hatmi; Mohammad Vafaei Moghaddam; G Sybren de Hoog; Iman Haghani; Seyed Reza Aghili; Tahereh Shokohi; Mohammad Taghi Hedayati; Roshanak Daie Ghazvini; Reza Kachuei; Ali Rezaei-Matehkolaei; Koichi Makimura; Jacques F Meis; Hamid Badali
Journal:  Antimicrob Agents Chemother       Date:  2018-04-26       Impact factor: 5.191

6.  Comparative Evaluation of Etest, EUCAST, and CLSI Methods for Amphotericin B, Voriconazole, and Posaconazole against Clinically Relevant Fusarium Species.

Authors:  Abdullah M S Al-Hatmi; Anne-Cécile Normand; Stephane Ranque; Renaud Piarroux; G Sybren de Hoog; Joseph Meletiadis; Jacques F Meis
Journal:  Antimicrob Agents Chemother       Date:  2016-12-27       Impact factor: 5.191

7.  Accurate and practical identification of 20 Fusarium species by seven-locus sequence analysis and reverse line blot hybridization, and an in vitro antifungal susceptibility study.

Authors:  He Wang; Meng Xiao; Fanrong Kong; Sharon Chen; Hong-Tao Dou; Tania Sorrell; Ruo-Yu Li; Ying-Chun Xu
Journal:  J Clin Microbiol       Date:  2011-03-09       Impact factor: 5.948

8.  Rare arthroconidial fungi in clinical samples: Scytalidium cuboideum and Arthropsis hispanica.

Authors:  Alejandra Giraldo; Deanna A Sutton; Josepa Gené; Annette W Fothergill; Josep Cano; Josep Guarro
Journal:  Mycopathologia       Date:  2012-10-17       Impact factor: 2.574

9.  Less-frequent Fusarium species of clinical interest: correlation between morphological and molecular identification and antifungal susceptibility.

Authors:  Mónica Azor; Josepa Gené; Josep Cano; Palanisamy Manikandan; Narendran Venkatapathy; Josep Guarro
Journal:  J Clin Microbiol       Date:  2009-03-25       Impact factor: 5.948

Review 10.  Fusariosis, a complex infection caused by a high diversity of fungal species refractory to treatment.

Authors:  J Guarro
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-08-11       Impact factor: 3.267
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.